platoseedplatoseed
Predicting and preventing heart disease.
Bodyport’s cardiovascular sensing weight scale and predictive algorithms detect early changes in cardiac function to help prevent avoidable hospitalizations. Bodyport is initially targeting heart failure, a chronic condition affecting over 6M Americans and a leading cause of hospitalizations (1M/year) and healthcare spending ($35B/year). Bodyport’s novel scale measures cardiac output, congestion, heart rate, and other leading indicators of cardiovascular health — all in the same step patients already take to weigh themselves. Companion algorithms and software empower care teams to quickly identify at-risk patients and remotely optimize their therapy to prevent deterioration.
Bodyport offers a fluid management platform for heart failure care, combining a non-invasive cardiac scale with an advanced congestion index and a connected care platform to enable early detection and proactive intervention from home.
The solution uses the Bodyport Cardiac Scale to non-invasively measure hemodynamic biomarkers via the feet and transmit data to the care team within minutes. The Congestion Index combines multiple biomarkers into a single metric to detect early worsening heart failure with higher sensitivity and fewer false alerts. The platform includes a Care Portal for clinicians, a patient app for engagement, and a robust API for EHR/third-party integrations, along with RPM billing support and HIPAA/SOC 2 compliance. It also tracks engagement and documents clinical activities for compliance.
Who it’s for: Healthcare systems, clinicians, and researchers managing patients with heart failure requiring remote monitoring and proactive management.
Evidence-based validation in peer-reviewed studies; partnerships with health systems; clinical study results published; emphasis on research and real-world practice.
Biomedical engineer developing medical devices to improve cardiac health.
Digital hematology
Makers of simple, affordable medical devices. Our award-winning…
